Immune Cell Therapies and Immune Cell Engineering

Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis
Celine Man Ying Li, Yoko Tomita, Bimala Dhakal, Runhao Li, Jun Li, Paul Drew, Timothy Price, Eric Smith, Guy J Maddern, Kevin Aaron Fenix

Journal for ImmunoTherapy of Cancer Apr 2023, 11 (4) e006764; DOI: 10.1136/jitc-2023-006764
Engineering second-generation TCR-T cells by site-specific integration of TRAF-binding motifs into the CD247 locus
Sangjoon Lah, Segi Kim, In Kang, Hyojin Kim, Cedric Hupperetz, Hyuncheol Jung, Hyeong Ryeol Choi, Young-Ho Lee, Hyeon-Ki Jang, Sangsu Bae, Chan Hyuk Kim

Journal for ImmunoTherapy of Cancer Apr 2023, 11 (4) e005519; DOI: 10.1136/jitc-2022-005519
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Hongping Ba, Zigang Dai, Zunyue Zhang, Peng Zhang, Bingjiao Yin, Jing Wang, Zhuoya Li, Xiaoxi Zhou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e003837; DOI: 10.1136/jitc-2021-003837
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses
Camilla Bove, Silvia Arcangeli, Laura Falcone, Barbara Camisa, Rita El Khoury, Beatrice Greco, Anna De Lucia, Alice Bergamini, Attilio Bondanza, Fabio Ciceri, Chiara Bonini, Monica Casucci

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005878; DOI: 10.1136/jitc-2022-005878
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
Marc Pfefferlé, Irina L Dubach, Raphael M Buzzi, Elena Dürst, Nadja Schulthess-Lutz, Livio Baselgia, Kerstin Hansen, Larissa Imhof, Sandra Koernig, Didier Le Roy, Thierry Roger, Rok Humar, Dominik J Schaer, Florence Vallelian

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005718; DOI: 10.1136/jitc-2022-005718
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
Ming Sun, Yingying Cao, Reona Okada, Jeyshka M Reyes-González, Hannah G Stack, Haiying Qin, Nan Li, Charlie Seibert, Michael C Kelly, Eytan Ruppin, Mitchell Ho, Carol J Thiele, Rosa Nguyen

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005881; DOI: 10.1136/jitc-2022-005881
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Mary K McKenna, Ada Ozcan, Daniel Brenner, Norihiro Watanabe, Maureen Legendre, Dafydd G Thomas, Christopher Ashwood, Richard D Cummings, Challice Bonifant, David M Markovitz, Malcolm K Brenner

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005891; DOI: 10.1136/jitc-2022-005891
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2⁺ patients with diffuse midline glioma
Lena Immisch, George Papafotiou, Oliver Popp, Philipp Mertins, Thomas Blankenstein, Gerald Willimsky

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005535; DOI: 10.1136/jitc-2022-005535
Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes
Chaoting Zhang, Yizhe Sun, Shance Li, Luyan Shen, Xia Teng, Yefei Xiao, Nan Wu, Zheming Lu

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e004868; DOI: 10.1136/jitc-2022-004868
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Kristin M Snyder, Kate J Dixon, Zachary Davis, Martin Hosking, Geoffrey Hart, Melissa Khaw, Anders Matson, Ryan Bjordahl, Bryan Hancock, Soheila Shirinbak, Jeffrey S Miller, Bahram Valamehr, Jianming Wu, Bruce Walcheck

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007280; DOI: 10.1136/jitc-2023-007280

Main menu

Immune Cell Therapies and Immune Cell Engineering

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immune Cell Therapies and Immune Cell Engineering

Pages